Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-cd9895bd7-p9bg8 Total loading time: 0 Render date: 2024-12-28T21:58:09.242Z Has data issue: false hasContentIssue false

Chapter 8 - Catamenial Epilepsy

Published online by Cambridge University Press:  19 December 2024

By
Alexa King  and
Elizabeth E. Gerard
Edited by
Esther Bui  and
P. Emanuela Voinescu
Esther Bui
Affiliation:
Toronto Western Hospital
P. Emanuela Voinescu
Affiliation:
Brigham & Women's Hospital, Boston, MA
Get access

Summary

Catamenial epilepsy is a pattern of seizure exacerbation from sensitivity to hormonal changes throughout the menstrual cycle. This hormonal sensitivity is common, occurring in approximately one third of women with epilepsy. There are three patterns of catamenial epilepsy, with the perimenstrual (C1) pattern occurring most frequently. The pathophysiology of catamenial epilepsy is complex, but studies suggest that it is primarily due to the fluctuations in the ratio of estrogen to progesterone throughout the menstrual cycle, with a worsening of seizures at times of increased estrogen-to-progesterone ratio. Therapies for catamenial seizures that have been described include hormonal therapies such as progesterone supplementation and cycle suppression. Non-hormonal therapies including pulse-dosed medications as well as optimization of anti-seizure medications at specific times in the menstrual cycle have been tried. Evidence for specific treatment of catamenial epilepsy, however, remains sparse and no highly effective treatment has been described. A few studies suggest that patients with hormone sensitive seizures may have specific responses in pregnancy, perimenopause and menopause, however further prospective studies are needed.

Keywords

Catamenial epilepsyWomen with epilepsyPerimenstrual seizureProgesteroneEstrogen
Type
Chapter
Information
Women with Epilepsy
A Practical Management Handbook
 , pp. 134 - 148
Publisher: Cambridge University Press
Print publication year: 2025

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Foldvary-Schaefer, N, Harden, C, Herzog, A, et al. Hormones and seizures. Cleveland Clinic Journal of Medicine. 2004;71(2):S11–S8.CrossRefGoogle ScholarPubMed
Logothetis, J, Harner, R, Morrell, F, Torres, F. The role of estrogens in catamenial exacerbation of epilepsy. Neurology. 1959;9(5):352–60.CrossRefGoogle ScholarPubMed
Woolley, CS. Estradiol facilitates kainic acid-induced, but not flurothyl-induced, behavioral seizure activity in adult female rats. Epilepsia. 2000;41(5):510–15.CrossRefGoogle Scholar
Hom, AC, Butterbough, GG. Estrogen alters the acquisition of seizures kindled by repeated amygdala stimulation or pentylenetetrazol administration in ovariectomized female rats. Epilepsia. 1986;27:103–8.Google ScholarPubMed
Backstrom, T. Epileptic seizures in women related to plasma estrogen and progesterone during the menstrual cycle. Acta Neurologica Scandinavia. 1976;54(4):321–47.CrossRefGoogle ScholarPubMed
Woolley, CS, McEwen, BS. Estradiol regulates hippocampal dendritic spine density via an N-methyl-D-aspartate receptor-dependent mechanism. Neuroscience. 1994;14(12):7680–7.Google ScholarPubMed
Veliskova, J, De Jesus, G, Kaur, R, et al. Females, their estrogens, and seizures. Epilepsia. 2010;51(3):141–4.CrossRefGoogle ScholarPubMed
Reddy, DS. Neuroendocrine aspects of catamenial epilepsy. Hormones and Behavior. 2013;63(2):254–66.CrossRefGoogle ScholarPubMed
Reddy, DS. Role of neurosteroids in catamenial epilepsy. Epilepsy Research. 2004;62(2–3):99–118.CrossRefGoogle ScholarPubMed
Herzog, AG. Hormonal therapies: Progesterone. Neurotherapeutics. 2009;6(2):383–91.CrossRefGoogle ScholarPubMed
Reddy, DS, Rogawski, MA. Neurosteroid replacement therapy for catamenial epilepsy. Epilepsy. 2010;6:501–13.CrossRefGoogle Scholar
Kapur, J, Joshi, S. Progesterone modulates neuronal excitability bidirectionally. Neuroscience Letters. 2021;744:135619.CrossRefGoogle ScholarPubMed
Joshi, S, Sun, H, Rajasekaran, K, et al. A novel therapeutic approach for treatment of catamenial epilepsy. Neurobiology of Disease. 2018;111:127–37.CrossRefGoogle ScholarPubMed
Shiono, S, Sun, H, Batabyal, T, et al. Limbic progesterone receptor activity enhances neuronal excitability and seizures. Epilepsia. 2021; 62(8):1946–59.CrossRefGoogle ScholarPubMed
Ansell, B, Clarke, E. Epilepsy and menstruation: The role of water retention. Lancet. 1956;271(6955):1232–5.Google ScholarPubMed
de Wildt, SN, Kearns, GL, Leeder, JS, van den Anker, JN. Glucuronidation in humans: Pharmacogenetic and developmental aspects. Clin Pharmacokinet. 1999;36(6):439–52.CrossRefGoogle ScholarPubMed
Isojärvi, JIT, Taubøll, E, Herzog, AG. Effect of antiepileptic drugs on reproductive endocrine function in individuals with epilepsy. CNS Drugs. 2005;19(3):207–23.Google ScholarPubMed
Rosciszewski, D, Buntner, B, Guz, I, et al. Ovarian hormones, anticonvulsant drugs, and seizures during the menstrual cycle in women with epilepsy. J Neurol Neurosurg Psychiatry. 1986;49(1):47–51.CrossRefGoogle Scholar
Kumar, N, Behari, M, Ahuja, GK, Jailkhani, BL. Phenytoin levels in catamenial epilepsy. Epilepsia. 1988;29(2):155–8.CrossRefGoogle ScholarPubMed
Shavit, G, Lerman, P, Korczyn, AD, et al. Phenytoin pharmacokinetics in catamenial epilepsy. Neurology. 1984;34(7):959–61.CrossRefGoogle ScholarPubMed
Herkes, G, Eadie, MJ. Possible roles for frequent salivary AED monitoring in the management of epilepsy. Epilepsy Res Suppl. 1990;6:146–54.Google Scholar
Herzog, AG, Fowler, KM, Smithson, SD. Valproate and lamotrigine level variation with menstrual cycle phase and oral contraceptive use. Neurology. 2009;72:911–14.CrossRefGoogle ScholarPubMed
Foldvary-Schaefer, N, Falcone, T. Catamenial epilepsy: Pathophysiology, diagnosis, and management. Neurology. 2003;61:S2–15.CrossRefGoogle ScholarPubMed
Herzog, AG, Klein, P, Rand, BJ. Three patterns of catamenial epilepsy. Epilepsia. 1997;38(18):1082–8.CrossRefGoogle ScholarPubMed
Herzog, AG, Harden, CL, Liporace, J, et al. Frequency of catamenial seizure exacerbation in women with localization-related epilepsy. Annals of Neurology. 2004;56(3):431–4.CrossRefGoogle ScholarPubMed
Quigg, M, Smithson, SD, Fowler, KM, Susal, T, Herzog, AG. Laterality and location influence catamenial seizure expression in women with partial epilepsy. Neurology. 2009;73:224–7.CrossRefGoogle ScholarPubMed
Kalinin, VV, Zheleznova, EV . Chronology and evolution of temporal lobe epilepsy and endocrine reproductive dysfunction in women: Relationships to side of focus and catameniality. Epilepsy & Behavior. 2007;11:185–91.CrossRefGoogle ScholarPubMed
Kamitaki, BK, Janmohamed, M, Kandula, P, et al. Clinical and EEG factors associated with antiseizure medication resistance in idiopathic generalized epilepsy. Epilepsia. 2022;63:150–61.CrossRefGoogle ScholarPubMed
Duncan, S, Read, CL, Brodie, MJ. How common is catamenial epilepsy? Epilepsia. 1993;34(5):827–31.CrossRefGoogle ScholarPubMed
Gerard, EE, Meador, KJ. Managing epilepsy in women. Continuum. 2016;22:204–26.Google ScholarPubMed
Maguire, MJ, Nevitt, SJ. Treatments for seizures in catamenial (menstrual-related) epilepsy. Cochrane Database of Systematic Reviews. 2019;9(9):CD013225.Google Scholar
Dana‐Haeri, J, Richens, A. Effect of norethisterone on seizures associated with menstruation. Epilepsia. 1983;24(3):377–81.CrossRefGoogle ScholarPubMed
Herzog, AG, Fowler, KM, Smithson, SD, et al. Progesterone vs. placebo therapy for women with epilepsy: A randomized clinical trial. Neurology. 2012;78(24):1959–66.CrossRefGoogle ScholarPubMed
Najafi, M, Sadeghi, MM, Mehvari, J, Zare, M, Akbari, M. Progesterone therapy in women with intractable catamenial epilepsy. Advanced Biomedical Research. 2013;2(1):P8.Google ScholarPubMed
Reddy, DS, Rogawski, MA. Enhanced anticonvulsant activity of neuroactive steroids in a rat model of catamenial epilepsy. Epilepsia. 2001;42(3):337–44.CrossRefGoogle Scholar
McAuley, J, Moore, JL, Reeves, AL, et al. A pilot study of the neurosteroid ganaxolone in catamenial epilepsy: Clinical experience in two patients. Epilepsia. 2001;42:P85.Google Scholar
Sperling, MR, Klein, P, Tsai, J. Randomized, double-blind, placebo-controlled phase 2 study of ganaxolone as add-on therapy in adults with uncontrolled partial-onset seizures. Epilepsia. 2017;58(4):558–64.CrossRefGoogle ScholarPubMed
Mattson, RH, Cramer, JA, Caldwell, BV, Siconolfi, BC. Treatment of seizures with medroxyprogesterone acetate: Preliminary report. Neurology. 1984;34(9):1255–8.CrossRefGoogle ScholarPubMed
Phan, T, Nur, M. Improvement in seizure control after initiation of depot medroxyprogesterone acetate. Journal of Pediatric and Adolescent Gynecology. 2017;30(2):325–6.CrossRefGoogle Scholar
Pennell, PB. Hormonal aspects of epilepsy. Neurologic Clinics. 2009;27(4):941–65.CrossRefGoogle ScholarPubMed
Herzog, AG. Clomiphene therapy in epileptic women with menstrual disorders. Neurology. 1988;38(3):32–434.CrossRefGoogle ScholarPubMed
Bauer, J, Wild, L, Flügel, D, Stefan, H. The effect of a synthetic GnRH analogue on catamenial epilepsy: A study in ten patients. Journal of Neurology. 1992;239(5):284–6.CrossRefGoogle ScholarPubMed
Ichida, M, Gomi, A, Hiranouchi, N, et al. A case of cerebral endometriosis causing catamenial epilepsy. Neurology. 1993;43(12):2708–9.CrossRefGoogle ScholarPubMed
Vilos, GA, Hollett-Caines, J, Abu-Rafea, B, Ahmad, R, Mazurek, MF. Resolution of catamenial epilepsy after goserelin therapy and oophorectomy: Case report of presumed cerebral endometriosis. Journal of Minimally Invasive Gynecology. 2011;18(1):128–30.CrossRefGoogle ScholarPubMed
Feely, M, Calvert, R, Gibson, J. Clobazam in catamenial epilepsy: A model for evaluating anticonvulsants. Lancet. 1982;2(8289):71–3.Google Scholar
Feely, M, Gibson, J. Intermittent clobazam for catamenial epilepsy: Tolerance avoided. Journal of Neurology, Neurosurgery and Psychiatry. 1984;47(12):1279–82.CrossRefGoogle ScholarPubMed
Anderson, RE, Howard, RA, Woodbury, DM. Correlation between effects of acute acetazolamide administration to mice on electroshock seizure threshold and maximal electroshock seizure pattern, and on carbonic anhydrase activity in subcellular fractions of brain. Epilepsia. 1986;27(5):504–9.CrossRefGoogle ScholarPubMed
Lim, LL, Foldvary, N, Mascha, E, Lee, J. Acetazolamide in women with catamenial epilepsy. Epilepsia. 2001;42(6):746–9.CrossRefGoogle ScholarPubMed
Falardeau, J, Lobb, BM, Golden, S, Maxfield, SD, Tanne, E. The use of acetazolamide during pregnancy in intracranial hypertension patients. Journal of Neuro-ophthalmology. 2013;33(1):9–12.CrossRefGoogle ScholarPubMed
Thomas, SV, Jose, M, Divakaran, S, Sankara Sarma, P. Malformation risk of antiepileptic drug exposure during pregnancy in women with epilepsy: Results from a pregnancy registry in south India. Epilepsia. 2017;58(2):274–81.CrossRefGoogle ScholarPubMed
Pack, AM. Having catamenial epilepsy equals fewer seizures in pregnancy. Epilepsy Currents. 2015;15(3):124–5.CrossRefGoogle ScholarPubMed
Cagnetti, C, Lattanzi, S, Foschi, N, Provinciali, L, Silvestrini, M. Seizure course during pregnancy in catamenial epilepsy. Neurology. 2014;83(4):339–44.CrossRefGoogle ScholarPubMed
Pennell, PB, French, JA, May, RC, et al. Changes in seizure frequency and antiepileptic therapy during pregnancy. New England Journal of Medicine. 2020;383(26):2547–56.CrossRefGoogle ScholarPubMed
Harden, CL, Pulver, MC, Ravelin, L, Jacobs, AR. The effect of menopause and perimenopause on the course of epilepsy. Epilepsia. 1999;40(10):1402–7.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×